RSS Feed

Portfolio News

July 24, 2012 - Dow Jones VentureWireHistogenics Closes $49M Series A for Phase III Studies of Cartilage Implant
July 19, 2012 - Dow Jones VentureWirePharmaceutical Developer Durata Trades Up 8.1% Post-IPO
July 18, 2012 - Dow Jones VentureWireSofinnova Ventures, NEA Join $40M PIPE For Alimera Sciences
July 02, 2012 Amarin Announces Notice of Allowance for Additional U.S. Patent Covering AMR101
July 02, 2012 Tesaro’s 30% solution
June 28, 2012 Tesaro Completes $81M IPO; New Investor Sofinnova Joins Insiders in Offering
June 22, 2012 Volubill Named as a Leading Convergent Charging Software Provider by Infonetics Research
May 29, 2012 Amarin Announces U.S. Patent Issuance for AMR101
May 29, 2012 Cortina’s PON Innovation Accelerates Adoption in Fast Growing 10G EPON and EPON/GPON Markets
May 24, 2012 Data for Amarin's AMR101 to be Presented at the National Lipid Association 2012 Annual Scientific Sessions
May 22, 2012 Sorbent Therapeutics’ CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study
May 18, 2012 Ocera Therapeutics receives CE Mark for Zysa(TM) for the treatment of diarrhea-predominant Irritable Bowel Syndrome (IBS-d)
April 30, 2012 CrestaTech Secures $13M to Develop Smart Tuners for TV and Mobile Devices
April 13, 2012 Hyperion Therapeutics Files Registration Statement for Proposed Initial Public Offering
April 13, 2012 Guavus Sees Analytics As Key To Big Data

< More recent articles | Past articles >

Sofinnova News

November 03, 2012 - Sun SentinelBiotech Industry Aims for Growth
October 22, 2012 - Xconomy Who Will Survive the Biotech VC Downturn? The Young and the Proven
October 15, 2012 - XconomyWhich VCs Are Poised to Cash In On the Biotech IPOs of 2012? – Sofinnova Ventures
August 06, 2012 Glint of IPO Optimism
January 30, 2012 VCs Eye Bargain IPOs as Option for New Investment

< More recent | Past articles >

Events

October 28, 2013Mike Powell, BioNetwork West 2013 - "The Outlook for Traditional Venture Capital Firms: Evolving Trends and Opportunities"
October 22, 2013Sofinnova Japan BioPharma Partnering Conference
June 18, 2013Jennifer James, 2013 PEI Investor Relations Forum "Fundraising the next generation"
March 25, 2013Mike Powell, Lecture at UCSF - "Lessons Learned in Venture Capital: What I learned the Hard Way, the Easy Way, and from the Entrepreneurs"
February 12, 2013Anand Mehra Presents to Bio2Device Group

Media Contact

Jennifer James
VP of Marketing and Investor Relations
Sofinnova Ventures
jennifer@sofinnova.com
(650) 681-8429